1401, 18e rue
G2.609
Québec, QC
Canada G1J 1Z4
Dernières nouvelles
Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study
Article de revueFront Oncol, 14 , 2024.
Disseminated DIG-DIA With a Rare FMR1-RAF1 Fusion With Good Response to Targeted Therapy
Article de revuePediatr Blood Cancer, 2024.
Bevacizumab in the Treatment of Refractory Brain Edema in High-grade Glioma
Article de revueJ Pediatr Hematol Oncol, 46 (1), 2024.
Recurrent primary intracranial sarcoma, DICER1-mutant in a pediatric patient with DICER1 syndrome: the importance of molecular testing
Article de revueChilds Nerv Syst, 40 (6), 2024.
Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study
Article de revueFront Oncol, 14 , 2024.
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas
Article de revueCurr Oncol, 31 (7), 2024.
Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature
Article de revueJ Pediatr Hematol Oncol, 46 (4), 2024.
Advances in pediatric gliomas: from molecular characterization to personalized treatments
Article de revueEur J Pediatr, 183 (6), 2024.
MicroCLOTS pathophysiology in coronavirus disease 2019
Article de revueKorean J Intern Med, 38 (4), 2023.
Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors
Article de revueNeurooncol Adv, 5 (1), 2023.
Projets actifs
- Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients, du 2022-06-21 au 2027-12-25